• Weight Management

What is Oral Wegovy?

Published: December 31, 2025
Updated: December 31, 2025
4 mins

Wegovy® (semaglutide) is quickly becoming one of the most effective medications for chronic weight management since its FDA approval in 2021. This once-weekly injection has helped adults with obesity or weight-related health conditions lose significant amounts of weight when combined with diet and exercise.

Currently, patients inject Wegovy under the skin once weekly. While this method works well, it isn't right for everyone. Some people feel anxious about needles, while others experience discomfort at injection sites. Understanding these challenges, Novo Nordisk has been developing an oral version of semaglutide for weight management.

For the millions of Americans living with obesity, having choices matters. When patients can select a delivery method that fits comfortably into their daily routine, they're more likely to stay consistent with treatment. And consistency is key to achieving lasting results in weight management.

What is the Wegovy® Pill?

The Wegovy® pill is the oral form of semaglutide, the same medication found in injectable Wegovy. Both versions belong to a class of drugs called GLP-1 receptor agonists, which work by mimicking a natural hormone in your body that regulates appetite and blood sugar. 

The key difference lies in how the medication is delivered. Injectable Wegovy is administered once weekly under the skin, while oral Wegovy is taken as a daily tablet. 

Get prescription weight loss medication online.

Find out if you're eligible for GLP-1s, and get started on your weight loss journey for as low as $75/month.

Get Started

How is Oral Wegovy Different Than Other Oral GLP-1s?

It's important to understand that oral Wegovy is specifically formulated for weight management at higher doses. This distinguishes it from Rybelsus, another oral semaglutide product from Novo Nordisk that's been available since 2019 for type 2 diabetes. While they use the same core technology, Rybelsus is prescribed at lower doses for blood sugar control, whereas oral Wegovy is designed to provide the higher doses needed for significant weight loss.

Novo Nordisk began developing oral semaglutide for weight management after seeing the success of both injectable Wegovy and oral Rybelsus. Clinical trials have tested various doses to find the optimal balance between effectiveness and tolerability in patients seeking weight loss.

How Does Oral Wegovy Work?

Oral Wegovy works by mimicking a hormone your body naturally produces called GLP-1 (glucagon-like peptide-1). This hormone plays several important roles in regulating your metabolism, appetite, and how your body processes food.

When you eat, your intestines release GLP-1, which sends signals to your brain that you're full. It also slows down how quickly food moves through your stomach, helping you feel satisfied for longer periods. Semaglutide acts like an enhanced version of this hormone – it binds to the same receptors but stays active in your body much longer than natural GLP-1.

Here's what happens when you take oral Wegovy:

Appetite suppression: The medication activates receptors in areas of your brain that control hunger and fullness. Many patients describe feeling satisfied with smaller portions and experiencing fewer food cravings throughout the day.

Delayed gastric emptying: Semaglutide slows the movement of food from your stomach into your small intestine. This means you stay fuller longer after meals, which naturally reduces how much you eat.

Blood sugar regulation: The medication also helps your pancreas release insulin more efficiently when your blood sugar rises and reduces the release of glucagon (a hormone that raises blood sugar). While this effect is particularly beneficial for people with diabetes, it also contributes to weight loss by improving overall metabolic function.

The challenge of oral delivery

Getting semaglutide to work as a pill isn't straightforward. Normally, your stomach would break down this protein-based medication before it could reach your bloodstream. Novo Nordisk solved this problem in oral Wegovy by using an absorption enhancer called SNAC. 

This compound temporarily protects the medication from stomach acid and helps it pass through the stomach lining into your blood. This is why oral semaglutide must be taken on an empty stomach with specific instructions to maximize absorption and effectiveness.

How Well Does Oral Wegovy Work?

Clinical trials demonstrate that the Wegovy pill produces substantial weight loss when combined with a reduced-calorie diet and increased physical activity.

Weight loss results

In a 64-week study of 307 adults with obesity or overweight with weight-related health conditions, participants taking oral Wegovy lost an average of 14% of their body weight compared to 2.4% with placebo. Based on an average starting weight of about 234 pounds, this translates to roughly 33 pounds lost.

A larger trial (OASIS 1) with nearly 667 participants over 68 weeks showed even more impressive results, with patients losing 15.1% of their body weight on average compared to 2.4% with placebo.

Patient response rates

Not everyone responds identically, but the results are encouraging. In the 64-week study:

• 76% of patients lost at least 5% of their body weight

• 60% lost 10% or more

• 47% lost 15% or more

• 28% achieved 20% or more weight loss

These percentages far exceeded placebo (31%, 14%, 6%, and 3% respectively).

Oral vs. Injectable: Comparative Effectiveness

One of the most common questions patients ask is whether the pill works as well as the injection. The short answer: yes, they produce similar weight loss results.

Clinical studies show that oral Wegovy at its maximum dose of 25 mg daily produces meaningful weight loss comparable to injectable Wegovy. In the FDA approval trial, patients taking oral Wegovy lost an average of 14% of their body weight over 64 weeks, while injectable Wegovy trials have shown average weight loss of 15-16%. These results are clinically similar. Both formulations help patients achieve substantial, sustained weight loss.

Why the pill requires a higher milligram amount

You might wonder why the pill is 25 mg when the injection is only 2.4 mg weekly. It comes down to absorption. When you inject semaglutide under the skin, nearly all of it enters your bloodstream. 

When you swallow it as a pill, your digestive system breaks down most of it before it can be absorbed – only a small fraction makes it into your blood. The higher oral dose compensates for this difference, ultimately delivering comparable amounts of active medication to your body.

Dosing schedules

The two formulations require different routines:

Injectable Wegovy: One injection weekly, gradually increasing from 0.25 mg to a maintenance dose of 2.4 mg over several months. You can inject at any time of day, with or without food.

Wegovy pill: One pill daily, taken on an empty stomach with up to four ounces of water. You must wait at least 30 minutes before eating, drinking anything else, or taking other medications. The dose gradually increases from 1.5 mg to a maximum of 25 mg over several months.

The daily dosing requirement and strict timing instructions for oral Wegovy demand more attention to your morning routine compared to the once-weekly injection.

How do I know if the Wegovy pill or injection is right for me?

Neither option is inherently better. It depends on your preferences and lifestyle. If you're comfortable with injections and prefer less frequent dosing with no timing restrictions, injectable Wegovy may fit better into your life. If you have needle anxiety or simply prefer taking a pill, the oral version offers comparable weight loss despite requiring more attention to your daily routine.

The most important factor is choosing the option you'll take consistently. Long-term adherence is what determines success in weight management. The following table compares the pros and cons of both Wegovy options:

Side Effects of Oral Wegovy

Like all medications, oral Wegovy can cause side effects. Understanding what to expect helps you make an informed decision and know when to contact your healthcare provider.

The most frequent side effects involve your digestive system. These occur because semaglutide slows stomach emptying – the same mechanism that helps you feel full longer.

The most common issues include:

• Nausea: The most frequently reported side effect, affecting up to 40-50% of patients, especially when starting or increasing the dose

• Diarrhea: Experienced by approximately 30% of patients

• Vomiting: Occurs in about 20-25% of users

• Constipation: Affects roughly 20% of patients

• Abdominal pain or discomfort: Reported by 15-20% of people taking the medication

• Bloating and indigestion: Common but usually mild

Fortunately, these side effects are typically most pronounced when you first start the medication or increase your dose. For most patients, they diminish significantly over time as your body adjusts. This is why oral Wegovy uses a gradual dose escalation schedule – starting low and slowly increasing helps minimize digestive discomfort.

Ready to achieve your weight loss goals?

Shed pounds with GLP-1 medication prescribed online by licensed healthcare providers for as low as $75/month.

Get Started

How Much Will Oral Wegovy Cost?

Novo Nordisk has announced pricing for oral Wegovy that varies based on your insurance status and the dose you're taking.

With commercial insurance

If you have commercial insurance coverage for oral Wegovy, eligible patients can pay as little as $25 per month through Novo Nordisk's savings program. This significantly reduces out-of-pocket costs, though you'll need to meet your insurance plan's requirements for coverage, which typically include prior authorization and documentation of medical need.

Self-pay options

If you're paying out of pocket without insurance, costs depend on your dose:

• Lower doses (1.5 mg and 4 mg): Starting at $149 per month

  • Note: The 4 mg dose is offered at $149 only until April 15, 2026, after which it increases to $199 per month

• Higher doses (9 mg and 25 mg): $299 per month

These self-pay prices are considerably lower than injectable Wegovy's typical out-of-pocket cost, making the oral formulation more accessible for patients without insurance coverage. Keep in mind that you'll likely need to stay on the medication for several months to see significant results, so factor ongoing costs into your decision.

The $25 commercial insurance offer and self-pay pricing are available starting January 2, 2026. Eligibility requirements apply for the savings program, and it cannot be combined with government insurance like Medicare or Medicaid. Visit the Novo Nordisk website or talk to your pharmacist about enrollment when the medication becomes available.

When Will the Wegovy Pill Be Approved?

The Wegovy pill received FDA approval on December 22, 2025, making it the first and only oral GLP-1 medication approved specifically for weight loss. While oral semaglutide has been available since 2019 as Rybelsus for type 2 diabetes, this marks the first time an oral pill in this drug class has been approved for chronic weight management.

Novo Nordisk has announced that oral Wegovy will become available starting January 2, 2026. Patients interested in the medication should talk to their healthcare provider about whether it's appropriate for them. Your healthcare provider can write a prescription, though you may need to work with your insurance company for prior authorization if you're seeking coverage.

Where Can I Learn More About GLP-1s?

The LifeMD Weight Management Program offers personalized support to help you reach your weight goals. A licensed healthcare provider can work with you to determine if FDA-approved GLP-1 medications are right for your needs.

With guidance and options designed around your health, you can take steps toward weight management that fit your life.

See if you qualify today.